Laboratorios Farmaceuticos Rovi, S.A. (0ILL.L)
EUR 62.2
(0.97%)
EUR 62.2
(0.97%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 113.24 Million | 237.31 Million | 149.22 Million | 46.58 Million | -9.08 Million | 8.44 Million |
| Net Income | 170.33 Million | 199.66 Million | 153.07 Million | 61.05 Million | 39.27 Million | 17.89 Million |
| Depreciation & Amortization | 24.33 Million | 22.87 Million | 21.36 Million | 19.59 Million | 18.21 Million | 12.04 Million |
| Deferred income taxes | - | - | 95.09 Million | - | - | - |
| Stock-based compensation | - | - | 2.52 Million | - | - | - |
| Change in working capital | -10.52 Million | 516 Thousand | -29.08 Million | -40.88 Million | -63.66 Million | -24.43 Million |
| Other non-cash items | -70.89 Million | 116.74 Million | 108.85 Million | 109.73 Million | 97.2 Million | 51.44 Million |
| Investing Cash Flow | -52.02 Million | -57.16 Million | -40.9 Million | -39.62 Million | -40.52 Million | -26.34 Million |
| Investments in PPE | -53.79 Million | -51.38 Million | -40.94 Million | -39.69 Million | -40.52 Million | -26.45 Million |
| Acquisitions | 382 Thousand | 78 Thousand | 33 Thousand | 63 Thousand | 2000.00 | 62 Thousand |
| Investment purchases | -600 Thousand | -5.87 Million | - | - | - | - |
| Sales/Maturities of investments | 1.88 Million | 20 Thousand | - | - | - | 50 Thousand |
| Other Investing Activities | 1.76 Million | -6.43 Million | -621 Thousand | -288 Thousand | -14.57 Million | -9.85 Million |
| Financing Cash Flow | -160.84 Million | -154.24 Million | -62.44 Million | -21.21 Million | 21.52 Million | 72.7 Million |
| Debt repayment | -12.92 Million | -5.36 Million | -4.85 Million | -11.74 Million | -25.79 Million | -9.18 Million |
| Dividends payments | -69.04 Million | -51 Million | -21.13 Million | -9.7 Million | -4.42 Million | -5.95 Million |
| Common Stock Repurchased | -133.9 Million | -177 Million | -78.78 Million | -37.25 Million | -4.71 Million | -1.13 Million |
| Common Stock Issuance | 55.41 Million | 77.76 Million | 42.32 Million | 37.48 Million | 4.87 Million | 88.98 Million |
| Other Financing Activities | 55.02 Million | 1.37 Million | 42.04 Million | 37.18 Million | 4.77 Million | 88.79 Million |
| Accounts receivables | 19.47 Million | -26.82 Million | -74.18 Million | 7.46 Million | -20.4 Million | -9.6 Million |
| Accounts payables | -23.92 Million | 41.67 Million | 35.35 Million | -811 Thousand | 23.95 Million | 6.54 Million |
| Inventory | -29.29 Million | -71.59 Million | -23.42 Million | -70.39 Million | -67.22 Million | -21.34 Million |
| Other working capital | -702 Thousand | 57.25 Million | 33.16 Million | 22.86 Million | 18 Thousand | -21 Thousand |
| Cash at beginning of period | 124.94 Million | 99.03 Million | 53.16 Million | 67.42 Million | 95.51 Million | 42.07 Million |
| Cash at end of period | 25.32 Million | 124.94 Million | 99.03 Million | 53.16 Million | 67.42 Million | 95.51 Million |
| Capital Expenditure | -53.79 Million | -51.38 Million | -40.94 Million | -39.69 Million | -40.52 Million | -26.45 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -99.62 Million | 25.91 Million | 45.87 Million | -14.26 Million | -28.08 Million | 53.43 Million |
| Free Cash Flow | 59.45 Million | 185.92 Million | 108.28 Million | 6.88 Million | -49.61 Million | -18.01 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 29.38 Million | 14.96 Million | 170.33 Million | 51.5 Million | 52.18 Million | 19.18 Million |
| Depreciation & Amortization | 6.82 Million | 6.62 Million | 24.33 Million | 6.51 Million | 5.95 Million | 6.04 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -12.07 Million | 21.69 Million | -92.59 Million | 14.08 Million | -73.4 Million | 5.27 Million |
| Other non-cash items | -9.92 Million | -27.74 Million | 94.68 Million | -27.9 Million | 83.51 Million | 1.13 Million |
| Investing Cash Flow | -9.57 Million | -9.15 Million | -53.51 Million | -26.46 Million | -8.9 Million | -13.24 Million |
| Investments in PPE | -9.17 Million | -8.85 Million | -55.18 Million | -28.39 Million | -8.62 Million | -13.25 Million |
| Acquisitions | - | - | 382 Thousand | 133 Thousand | 239 Thousand | - |
| Investment purchases | - | - | -600 Thousand | -1.26 Million | -600 Thousand | - |
| Sales/Maturities of investments | - | - | 1.88 Million | 1.8 Million | 78 Thousand | 10 Thousand |
| Other Investing Activities | -406 Thousand | -298 Thousand | 1.76 Million | 1.26 Million | -112 Thousand | 549 Thousand |
| Financing Cash Flow | 26.86 Million | -18.62 Million | -160.45 Million | -65.69 Million | -88.65 Million | -3.03 Million |
| Debt repayment | -37.87 Million | -16.13 Million | -12.92 Million | -3.72 Million | -3.03 Million | -3.12 Million |
| Dividends payments | - | - | -69.04 Million | - | -69.04 Million | - |
| Common Stock Repurchased | -17.45 Million | -34.65 Million | -133.9 Million | -62.96 Million | -22.19 Million | -19 Million |
| Common Stock Issuance | - | - | 55.41 Million | 995 Thousand | 5.79 Million | 18.92 Million |
| Other Financing Activities | 6.44 Million | -99 Thousand | 55.02 Million | 897 Thousand | -171 Thousand | 171 Thousand |
| Accounts receivables | 7.94 Million | 19.09 Million | 19.47 Million | -22.24 Million | -12.46 Million | 28.65 Million |
| Accounts payables | - | - | -23.92 Million | 28.21 Million | -30.56 Million | 8.23 Million |
| Inventory | -18.76 Million | 2.7 Million | -29.29 Million | 23.95 Million | -13.18 Million | -27.8 Million |
| Other working capital | -1.25 Million | -101 Thousand | -58.84 Million | -15.83 Million | -17.18 Million | -3.81 Million |
| Cash at beginning of period | 13.08 Million | 25.32 Million | 124.94 Million | 56.37 Million | 153.81 Million | 141.46 Million |
| Cash at end of period | 44.57 Million | 13.08 Million | 25.32 Million | 25.32 Million | 56.37 Million | 153.81 Million |
| Capital Expenditure | -9.17 Million | -8.85 Million | -55.18 Million | -28.39 Million | -8.62 Million | -13.25 Million |
| Effect of forex changes on cash | - | - | - | -1.00 | - | - |
| Net cash flow / Change in cash | 31.49 Million | -12.23 Million | -99.62 Million | -31.05 Million | -97.43 Million | 12.35 Million |
| Free Cash Flow | 5.03 Million | 6.68 Million | 59.16 Million | 32.71 Million | -8.49 Million | 15.37 Million |
HBOR3
3166
KANDAGIRI
VIC
SLNHP
VICTMILL